OKYO (OKYO) Stock Price & Analysis
OKYO (OKYO) rose 4.73% to USD 1.55 as of July 25, 2026 at 15:04 UTC, according to Nexqual real-time market data.
OKYO last closed at USD 1.48; the session ranged USD 1.45–1.55 on volume of 45,226 shares. Market capitalization is $81.34M, with a 52-week range of USD 1.34–3.35 (NCM). Source: Nexqual, July 25, 2026 at 15:04 UTC.
Key Statistics (as of July 25, 2026 at 15:04 UTC)
| Price | USD 1.55 |
|---|---|
| Change | ▲ 4.73% (up) |
| Previous Close | USD 1.48 |
| Open | USD 1.48 |
| Day Range | USD 1.45 – 1.55 |
| 52-Week Range | USD 1.34 – 3.35 |
| Volume | 45,226 shares |
| Market Cap | $81.34M |
| Exchange | NCM |
Technical Analysis (OKYO)
Nexqual's technical model rates OKYO "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 15:04 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.32 (neutral) |
| vs SMA50 | Below (USD 1.58) |
| MACD | -0.03 (negative) |
Analyst Ratings (OKYO)
Wall Street analysts rate OKYO "Strong Buy" based on 3 analysts, with a mean price target of USD 8.33 (range USD 5–13), per Nexqual as of July 25, 2026 at 15:04 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 8.33 |
| High Target | USD 13 |
| Low Target | USD 5 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (OKYO)
| Revenue Estimate | $0 |
|---|
Source: Nexqual, July 25, 2026 at 15:04 UTC.
Financials & Fundamentals (OKYO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -263.78% |
| Current Ratio | 2.43 |
| Total Cash | $20.59M |
| Total Debt | $0 |
| Free Cash Flow | $-2.10M |
Source: Nexqual, July 25, 2026 at 15:04 UTC.
Financial Health Score (OKYO)
Nexqual rates OKYO's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 15:04 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $21M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -264%, ROA -43.1% |
Ownership (OKYO)
| Insider Ownership | +30.98% |
|---|---|
| Institutional Ownership | +20.81% |
| Shares Outstanding | 52.48M |
| Float | 27.99M |
| Short % of Float | +0.10% |
Source: Nexqual, July 25, 2026 at 15:04 UTC.
Major Backers & Investors (OKYO)
Notable institutional backers of OKYO include Woodline Partners LP, Maven Securities Limited, Stonepine Capital Management, LLC, according to Nexqual as of July 25, 2026 at 15:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Woodline Partners LP | 9.01% |
| Maven Securities Limited | 2.9% |
| Stonepine Capital Management, LLC | 2.1% |
| Balyasny Asset Management LP | 1.44% |
| UBS Group AG | 0.15% |
Source: Nexqual, July 25, 2026 at 15:04 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MAIA | MAIA Biotechnology, Inc. | USD 1.24 | ▼ 4.62% |
| SXTP | 60 Degrees Pharmaceuticals, Inc | USD 1.48 | ▼ 4.52% |
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.32 | ▲ 4.76% |
| SHPH | Shuttle Pharmaceuticals Holding | USD 2.89 | ▼ 5.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:04 UTC. This page is informational and not investment advice.